XML 37 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value of Financial Instruments
9 Months Ended
Sep. 27, 2015
Fair Value of Financial Instruments (Thousands of Dollars) [Abstract]  
Fair Value of Financial Instruments
(6) Fair Value of Financial Instruments

The Company measures certain financial instruments at fair value. The fair value hierarchy consists of three levels: Level 1 fair values are based on quoted market prices in active markets for identical assets or liabilities that the entity has the ability to access; Level 2 fair values are those based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and Level 3 fair values are based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Accounting standards permit entities to measure many financial instruments and certain other items at fair value and establish presentation and disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar assets and liabilities. The Company has elected the fair value option for certain available-for-sale investments. At September 27, 2015, September 28, 2014 and December 28, 2014, these investments totaled $22,834, $24,292 and $23,560, respectively, and are included in prepaid expenses and other current assets in the consolidated balance sheets. The Company recorded net losses of $176 and $246 on these investments in other (income) expense, net for the quarter and nine-months ended September 27, 2015, respectively, related to the change in fair value of such instruments.  For the quarter and nine-month periods ended September 28, 2014 the Company recorded net gains and interest income of $247 and $2,487, respectively, in other (income) expense, net, related to the change in fair value of such instruments.


At September 27, 2015, September 28, 2014 and December 28, 2014, the Company had the following assets and liabilities measured at fair value in its consolidated balance sheets:

    
Fair Value Measurements Using:
 
  
Fair
Value
  
Quoted
Prices in
Active
Markets
for
Identical
Assets
(Level 1)
  
Significant
Other
Observable
Inputs
(Level 2)
  
Significant
Unobservable
Inputs
(Level 3)
 
September 27, 2015
        
Assets:
        
Available-for-sale securities
 
$
26,863
   
4,029
   
11,664
   
11,170
 
Derivatives
  
119,123
   
-
   
119,123
   
-
 
Total assets
 
$
145,986
   
4,029
   
130,787
   
11,170
 
                 
Liabilities:
                
Derivatives
 
$
605
   
-
   
605
   
-
 
Option agreement
  
24,780
   
-
   
-
   
24,780
 
Total liabilities
 
$
25,385
   
-
   
605
   
24,780
 
                 
September 28, 2014
                
Assets:
                
Available-for-sale securities
 
$
31,097
   
6,805
   
18,632
   
5,660
 
Derivatives
  
41,475
   
-
   
41,475
   
-
 
Total assets
 
$
72,572
   
6,805
   
60,107
   
5,660
 
                 
Liabilities:
                
Derivatives
 
$
3,426
   
-
   
3,426
   
-
 
Option agreement
  
25,590
   
-
   
-
   
25,590
 
Total Liabilities
 
$
29,016
   
-
   
3,426
   
25,590
 
                 
December 28, 2014
                
Assets:
                
Available-for-sale securities
 
$
28,042
   
4,482
   
17,773
   
5,787
 
Derivatives
  
69,148
   
-
   
69,148
   
-
 
Total assets
 
$
97,190
   
4,482
   
86,921
   
5,787
 
                 
Liabilities:
                
Derivatives
 
$
2,591
   
-
   
2,591
   
-
 
Option agreement
  
25,340
   
-
   
-
   
25,340
 
Total Liabilities
 
$
27,931
   
-
   
2,591
   
25,340
 

Available-for-sale securities include equity securities of one company quoted on an active public market as well as certain investments valued at net asset values quoted on private markets that are not active. These net asset values are predominantly based on underlying investments which are traded on an active market; investments are redeemable within 45 days.  The Company also holds an available-for-sale investment which invests in hedge funds and contains financial instruments that are valued using certain estimates which are considered unobservable in that they reflect the investment manager's own assumptions about the inputs that market participants would use in pricing the asset or liability. The Company believes that these estimates are the best information available for use in the fair value of this investment.

The Company's derivatives consist primarily of foreign currency forward contracts. The Company uses current forward rates of the respective foreign currencies to measure the fair value of these contracts. The option agreement included in other liabilities at September 27, 2015, September 28, 2014 and December 28, 2014, is valued using an option pricing model based on the fair value of the related investment.  Inputs used in the option pricing model include the volatility and fair value of the underlying company which are considered unobservable inputs as they reflect the Company's own assumptions about the inputs that market participants would use in pricing the asset or liability. The Company believes that this is the best information available for use in the fair value measurement. There were no changes in these valuation techniques during the first nine months of 2015.
The following is a reconciliation of the beginning and ending balances of the fair value measurements of the Company's financial instruments which use significant unobservable inputs (Level 3):

  
2015
  
2014
 
Balance at beginning of year
 
$
(19,553
)
  
5,484
 
Purchases
  
5,000
   
-
 
Issuance of option agreement
  
-
   
(25,590
)
Gain from change in fair value
  
943
   
176
 
Balance at end of third quarter
 
$
(13,610
)
  
(19,930
)